• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本视力障碍的发病率及病因:首次针对新认证视力障碍者的全国性全面普查

Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals.

作者信息

Morizane Yuki, Morimoto Noriko, Fujiwara Atsushi, Kawasaki Ryo, Yamashita Hidetoshi, Ogura Yuichiro, Shiraga Fumio

机构信息

Department of Ophthalmology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho Kita-ku, Okayama, Okayama, 700-8558, Japan.

Department of Vision Informatics, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Jpn J Ophthalmol. 2019 Jan;63(1):26-33. doi: 10.1007/s10384-018-0623-4. Epub 2018 Sep 25.

DOI:10.1007/s10384-018-0623-4
PMID:30255397
Abstract

PURPOSE

To investigate the visual impairment certification status in Japan.

STUDY DESIGN

Observational cross-sectional study.

METHODS

We asked all welfare offices throughout Japan to submit data concerning age, sex, causative diseases, and visual impairment grades for newly certified visually impaired individuals aged ≥ 18 years in the fiscal year of 2015. The certification was based on criteria of the Act on Welfare of Physically Disabled Persons.

RESULTS

In total, data were collected for 12,505 newly certified visually impaired individuals. The most common age group for these individuals was 80-89 years (29.6%), followed by 70-79 (26.3%) and 60-69 (17.3%) years. The most common causative disease was glaucoma (28.6%), followed by retinitis pigmentosa (14.0%), diabetic retinopathy (12.8%), and macular degeneration (8.0%). Glaucoma was the most common causative disease in both sexes (30.2% in men and 27.0% in women). The most common impairment grade was grade 2 (31.8%), followed by grades 5 (24.3%) and grade 1 (16.1%). The number of visually impaired individuals with underlying glaucoma had increased in comparison with the number in the most recent surveys (from fiscal years 2007 to 2009), whereas the number of individuals with underlying diabetic retinopathy and macular degeneration had decreased.

CONCLUSION

To our knowledge, this is the first nation-wide complete enumeration survey of newly certified visually impaired individuals in Japan. These findings may contribute to administrative activities concerning medical welfare as well as educational activities for preventing visual impairment.

摘要

目的

调查日本视力障碍认证情况。

研究设计

观察性横断面研究。

方法

我们要求日本各地所有福利办公室提交2015财年新认证的年龄≥18岁视力障碍者的年龄、性别、致病疾病及视力障碍等级数据。认证依据《身体残疾人福利法》标准。

结果

总共收集了12505名新认证视力障碍者的数据。这些人的最常见年龄组为80 - 89岁(29.6%),其次是70 - 79岁(26.3%)和60 - 69岁(17.3%)。最常见的致病疾病是青光眼(28.6%),其次是色素性视网膜炎(14.0%)、糖尿病性视网膜病变(12.8%)和黄斑变性(8.0%)。青光眼是男女中最常见的致病疾病(男性为30.2%,女性为27.0%)。最常见的障碍等级为2级(31.8%),其次是5级(24.3%)和1级(16.1%)。与最近几次调查(2007财年至2009财年)相比,潜在青光眼导致的视力障碍者数量有所增加,而潜在糖尿病性视网膜病变和黄斑变性导致的视力障碍者数量有所减少。

结论

据我们所知,这是日本首次针对新认证视力障碍者进行的全国范围的完整普查。这些发现可能有助于医疗福利相关行政活动以及预防视力障碍的教育活动。

相似文献

1
Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals.日本视力障碍的发病率及病因:首次针对新认证视力障碍者的全国性全面普查
Jpn J Ophthalmol. 2019 Jan;63(1):26-33. doi: 10.1007/s10384-018-0623-4. Epub 2018 Sep 25.
2
A nationwide survey of newly certified visually impaired individuals in Japan for the fiscal year 2019: impact of the revision of criteria for visual impairment certification.2019 财年日本新认定视力障碍者的全国性调查:视力障碍认定标准修订的影响。
Jpn J Ophthalmol. 2023 May;67(3):346-352. doi: 10.1007/s10384-023-00986-9. Epub 2023 Apr 17.
3
Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan.日本三重县10年间视力障碍的年发病率。
Jpn J Ophthalmol. 2017 Jul;61(4):293-298. doi: 10.1007/s10384-017-0517-x. Epub 2017 Apr 26.
4
[Causes of visual impairment in Mie Prefecture during a 5-year period].[三重県県5年间の視力障害の原因]
Nippon Ganka Gakkai Zasshi. 2010 Jun;114(6):505-11.
5
Five-year incidence of bilateral cause-specific visual impairment in the Melbourne Visual Impairment Project.墨尔本视力损害项目中双侧特定病因视力损害的五年发病率。
Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5075-81. doi: 10.1167/iovs.02-0457.
6
Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community.英国75岁及以上人群中导致视力损害的年龄相关性黄斑变性:医学研究委员会社区老年人评估与管理试验的一项附加研究。
Ophthalmology. 2004 Mar;111(3):513-7. doi: 10.1016/j.ophtha.2003.07.012.
7
[Causes and prevalence of visual impairment in Japan].[日本视力障碍的原因及患病率]
Nippon Ganka Gakkai Zasshi. 2014 Jun;118(6):495-501.
8
The association between legal Japanese visual impairment grades and vision-related quality of life.日本法定视力损害等级与视力相关生活质量之间的关联。
Jpn J Ophthalmol. 2016 May;60(3):219-25. doi: 10.1007/s10384-016-0437-1. Epub 2016 Mar 14.
9
A nationwide population-based survey on visual acuity, near vision, and self-reported visual function in the adult population in Finland.芬兰一项基于全国人口的成年人视力、近视力及自我报告视觉功能的调查。
Ophthalmology. 2005 Dec;112(12):2227-37. doi: 10.1016/j.ophtha.2005.09.010.
10
[The causes of childhood blindness and visual impairment in Poland].[波兰儿童失明及视力损伤的原因]
Klin Oczna. 2001;103(2-3):117-20.

引用本文的文献

1
Advancements in robotic surgery for vitreoretinal diseases: current trends and the future.玻璃体视网膜疾病机器人手术的进展:当前趋势与未来
Jpn J Ophthalmol. 2025 Jul;69(4):483-494. doi: 10.1007/s10384-025-01231-1. Epub 2025 Aug 1.
2
Exploratory Analysis of Serum Oxidized Albumin as a Potential Prognostic Indicator for Diabetic Microvascular Complications: A Retrospective Cohort Pilot Study.血清氧化型白蛋白作为糖尿病微血管并发症潜在预后指标的探索性分析:一项回顾性队列初步研究。
Cureus. 2025 May 12;17(5):e83976. doi: 10.7759/cureus.83976. eCollection 2025 May.
3
Efficacy of switching from existing anti-vascular endothelial growth factor drugs to ranibizumab biosimilar in neovascular age-related macular degeneration.

本文引用的文献

1
Aqueous shunts for glaucoma.用于青光眼的房水引流装置
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD004918. doi: 10.1002/14651858.CD004918.pub3.
2
Safety and Efficacy of Microinvasive Glaucoma Surgery.微创青光眼手术的安全性与有效性
J Ophthalmol. 2017;2017:3182935. doi: 10.1155/2017/3182935. Epub 2017 Apr 23.
3
Annual incidences of visual impairment during 10-year period in Mie prefecture, Japan.日本三重县10年间视力障碍的年发病率。
在新生血管性年龄相关性黄斑变性中,从现有抗血管内皮生长因子药物转换为雷珠单抗生物类似药的疗效。
Jpn J Ophthalmol. 2025 Jun 12. doi: 10.1007/s10384-025-01224-0.
4
Identification of organizational issues during initial medical care for patients with glaucoma.青光眼患者初始医疗护理期间组织问题的识别。
Int Ophthalmol. 2025 Mar 30;45(1):133. doi: 10.1007/s10792-025-03521-6.
5
Study protocol for a prospective natural history registry investigating the relationships between inflammatory markers and disease progression in retinitis pigmentosa: the RP-PRIMARY study.一项前瞻性自然史登记研究的研究方案,该研究旨在调查色素性视网膜炎中炎症标志物与疾病进展之间的关系:RP-PRIMARY研究。
Jpn J Ophthalmol. 2025 Mar 5. doi: 10.1007/s10384-025-01179-2.
6
Extent of Complete Retinal Pigment Epithelial and Outer Retinal Atrophy with Foveal Center Involvement is Associated with Visual Acuity.伴有黄斑中心凹受累的完全性视网膜色素上皮和外层视网膜萎缩程度与视力相关。
Ophthalmol Sci. 2024 Aug 29;5(1):100612. doi: 10.1016/j.xops.2024.100612. eCollection 2025 Jan-Feb.
7
Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial.雷珠单抗联合鲁索替尼治疗2型糖尿病性黄斑水肿:一项随机临床试验。
Diabetes Obes Metab. 2025 May;27(5):2473-2484. doi: 10.1111/dom.16244. Epub 2025 Feb 11.
8
Analysis of the aqueous humor before and after the administration of faricimab in patients with nAMD.在湿性年龄相关性黄斑变性(nAMD)患者中,分析玻璃体内注射faricimab前后的房水情况。
Sci Rep. 2024 Dec 30;14(1):31951. doi: 10.1038/s41598-024-83473-6.
9
Outcomes, efficacy and risk factors of 27-Gauge vitrectomy for diabetic tractional retinal detachment in Japanese patients.日本患者糖尿病性牵拉性视网膜脱离27G玻璃体切除术的治疗结果、疗效及危险因素
Jpn J Ophthalmol. 2025 Jan;69(1):59-65. doi: 10.1007/s10384-024-01135-6. Epub 2024 Nov 6.
10
Factors Affecting Visual Acuity After Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration: A Multicenter Study in Japan.日本一项多中心研究:影响新生血管性年龄相关性黄斑变性抗血管内皮生长因子治疗后视力的因素
J Clin Med. 2024 Oct 19;13(20):6244. doi: 10.3390/jcm13206244.
Jpn J Ophthalmol. 2017 Jul;61(4):293-298. doi: 10.1007/s10384-017-0517-x. Epub 2017 Apr 26.
4
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.自体诱导干细胞衍生的视网膜细胞治疗黄斑变性。
N Engl J Med. 2017 Mar 16;376(11):1038-1046. doi: 10.1056/NEJMoa1608368.
5
Fornix-Based Versus Limbal-Based Conjunctival Trabeculectomy Flaps for Glaucoma: Findings From a Cochrane Systematic Review.用于青光眼的穹窿部结膜小梁切除术瓣与角膜缘部结膜小梁切除术瓣:一项Cochrane系统评价的结果
Am J Ophthalmol. 2017 Feb;174:33-41. doi: 10.1016/j.ajo.2016.10.006. Epub 2016 Oct 26.
6
[Causes and prevalence of visual impairment in Japan].[日本视力障碍的原因及患病率]
Nippon Ganka Gakkai Zasshi. 2014 Jun;118(6):495-501.
7
New developments in diabetes management: medications of the 21st century.糖尿病管理的新进展:21世纪的药物
Clin Ther. 2014 Apr 1;36(4):477-84. doi: 10.1016/j.clinthera.2014.01.018. Epub 2014 Mar 1.
8
Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections.按病因和严重程度划分的日本成年人群视力损害患病率及未来预测。
Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):50-7. doi: 10.3109/09286580903450346.
9
Health-related and subjective quality of life of older adults with visual impairment.老年人视力障碍与健康相关的主观生活质量。
Disabil Rehabil. 2010;32(11):899-907. doi: 10.3109/09638280903349545.
10
Diabetes in Japan: a review of disease burden and approaches to treatment.日本的糖尿病:疾病负担与治疗方法的综述。
Diabetes Metab Res Rev. 2009 Nov;25(8):705-16. doi: 10.1002/dmrr.1012.